{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:40:32Z","timestamp":1777480832236,"version":"3.51.4"},"reference-count":48,"publisher":"Oceanside Publications Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["allergy asthma proc"],"published-print":{"date-parts":[[2022,5,1]]},"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Eosinophilic esophagitis (EoE) is a Type-2 chronic inflammatory food antigen\u2010driven disease of the esophagus, characterized by eosinophilic predominant inflammation and a constellation of symptoms. The incidence and prevalence of EoE has increased over\n the past 2 decades. There is an unmet need for approved less burdensome treatment options.  <jats:bold>Objective:<\/jats:bold> To describe the underlying pathophysiology and diagnosis of EoE and discuss the currently available treatment options. We also aim to review the new and emerging therapies\n for EoE.  <jats:bold>Methods:<\/jats:bold> A search of a medical literature data base was performed for articles that discuss treatment for EoE.  <jats:bold>Results:<\/jats:bold> A comparison of current therapies showed that dietary elimination, swallowed topical corticosteroids, and proton-pump inhibitor\n therapy are all effective for different populations. Emerging therapies that were reviewed include new topical corticosteroids and biologics directed against Type 2 inflammation.  <jats:bold>Conclusion:<\/jats:bold> EoE is a chronic inflammatory disorder that can be debilitating, with long-term\n sequelae. There are no current approved therapies in the United States. Numerous new treatments are on the horizon. Increasing amounts of data are helping to tailor treatment for each patient. Ultimately, shared decision-making is the best approach to guide treatment choices with patients\n to manage the ever-increasing burden of this disease.<\/jats:p>","DOI":"10.2500\/aap.2022.43.220014","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T04:32:07Z","timestamp":1651897927000},"page":"178-186","source":"Crossref","is-referenced-by-count":6,"title":["Current and emerging therapies for eosinophilic esophagitis"],"prefix":"10.2500","volume":"43","author":[{"given":"Ellen R.","family":"Sher","sequence":"first","affiliation":[{"name":"From the Department of Medicine, Rutgers Robert Wood Johnson Medical Center, Allergy Partners of New Jersey, Ocean, New Jersey;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline A.","family":"Ross","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jersey Shore University Medical Center, Allergy Partners of New Jersey, Ocean, New Jersey;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas M.","family":"Weine","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hackensack Meridian School of Medicine, Riverview Medical Center, Red Bank Gastroenterology, Allied Digestive Health, Red Bank, New Jersey; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arundhati","family":"Chandini Arjun","sequence":"additional","affiliation":[{"name":"Department of Medicine, Monmouth Medical Center, Rutgers Robert Wood Johnson Medical Center, Long Branch, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1355","reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2011.02.040","article-title":"Eosinophilic esophagitis: updated consensus recommendations for children and adults","volume":"128","author":"Liacouras","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1053\/j.gastro.2017.06.067","article-title":"Epidemiology and natural history of eosinophilic esophagitis","volume":"154","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"key":"B3","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/j.gastro.2018.07.009","article-title":"Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: proceedings of the AGREE Conference","volume":"155","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"key":"B4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/j.gastro.2017.06.065","article-title":"Pathophysiology of eosinophilic esophagitis","volume":"154","author":"O'Shea","year":"2018","journal-title":"Gastroenterology"},{"key":"B5","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.anai.2017.02.006","article-title":"Association between atopic manifestations and eosinophilic esophagitis: a systematic review and meta-analysis","volume":"118","author":"Gonz\u00e1lez-Cervera","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.gie.2006.04.037","article-title":"Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis","volume":"64","author":"Gonsalves","year":"2006","journal-title":"Gastrointest Endosc"},{"key":"B7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/gutjnl-2011-301817","article-title":"Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system","volume":"62","author":"Hirano","year":"2013","journal-title":"Gut"},{"key":"B8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cgh.2015.08.040","article-title":"Accuracy of the eosinophilic esophagitis endoscopic reference score in diagnosis and determining response to treatment","volume":"14","author":"Dellon","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B9","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/apt.14559","article-title":"Reliability of histologic assessment in patients with eosinophilic oesophagitis","volume":"47","author":"Warners","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"B10","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1053\/j.gastro.2013.08.015","article-title":"Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner","volume":"145","author":"Schoepfer","year":"2013","journal-title":"Gastroenterology"},{"key":"B11","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/ncp.10571","article-title":"Management of eosinophilic esophagitis: dietary and nondietary approaches","volume":"35","author":"Chen","year":"2020","journal-title":"Nutr Clin Pract"},{"key":"B12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2500\/aap.2019.40.4212","article-title":"Pearls and pitfalls in the management of eosinophilic esophagitis","volume":"40","author":"Holbreich","year":"2019","journal-title":"Allergy Asthma Proc"},{"key":"B13","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1053\/j.gastro.2020.02.039","article-title":"Technical review on the management of eosinophilic esophagitis: a report from the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters","volume":"158","author":"Rank","year":"2020","journal-title":"Gastroenterology"},{"key":"B14","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/ajg.2009.657","article-title":"Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation","volume":"105","author":"Schoepfer","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"B15","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/gutjnl-2012-302250","article-title":"Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD","volume":"62","author":"Cheng","year":"2013","journal-title":"Gut"},{"key":"B16","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/apt.12332","article-title":"Review article: proton pump inhibitor therapy for suspected eosinophilic oesophagitis","volume":"37","author":"Molina-Infante","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"B17","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/apt.12513","article-title":"The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor","volume":"38","author":"Vazquez-Elizondo","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"B18","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/MPG.0000000000001019","article-title":"High prevalence of response to proton-pump inhibitor treatment in children with esophageal eosinophilia","volume":"62","author":"Guti\u00e9rrez-Junquera","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B19","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/0016-5085(95)90637-1","article-title":"Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula","volume":"109","author":"Kelly","year":"1995","journal-title":"Gastroenterology"},{"key":"B20","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.cgh.2006.05.026","article-title":"Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis","volume":"4","author":"Kagalwalla","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B21","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jaci.2014.07.023","article-title":"Four-food group elimination diet for adult eosinophilic esophagitis: a prospective multicenter study","volume":"134","author":"Molina-Infante","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B22","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2014.02.006","article-title":"Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis","volume":"146","author":"Arias","year":"2014","journal-title":"Gastroenterology"},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2021.03.049","article-title":"A single food milk elimination diet is effective for treatment of eosinophilic esophagitis in children","author":"Wechsler","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B24","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1081-1206(10)61151-9","article-title":"Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests","volume":"95","author":"Spergel","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B25","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jaci.2017.08.038","article-title":"Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: the 2-4-6 study","volume":"141","author":"Molina-Infante","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B26","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.jaip.2018.06.012","article-title":"Eosinophilic esophagitis and the eosinophilic gastrointestinal diseases: approach to diagnosis and management","volume":"6","author":"Steinbach","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jpeds.2015.11.026","article-title":"Adrenal insufficiency after chronic swallowed glucocorticoid therapy for eosinophilic esophagitis","volume":"170","author":"Golekoh","year":"2016","journal-title":"J Pediatr"},{"key":"B28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/j.gastro.2019.03.014","article-title":"Efficacy of budesonide vs fluticasone for initial treatment of eosinophilic esophagitis in a randomized controlled trial","volume":"157","author":"Dellon","year":"2019","journal-title":"Gastroenterology"},{"key":"B29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/j.gastro.2019.03.025","article-title":"Efficacy of budesonide orodispersible tablets as induction therapy for eosinophilic esophagitis in a randomized placebo-controlled trial","volume":"157","author":"Lucendo","year":"2019","journal-title":"Gastroenterology"},{"key":"B30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.cgh.2021.04.022","article-title":"Budesonide oral suspension improves outcomes in patients with eosinophilic esophagitis: results from a phase 3 trial","volume":"20","author":"Hirano","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B31","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1053\/j.gastro.2010.07.048","article-title":"Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis","volume":"139","author":"Straumann","year":"2010","journal-title":"Gastroenterology"},{"key":"B32","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.gastro.2010.05.001","article-title":"Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial","volume":"139","author":"Dohil","year":"2010","journal-title":"Gastroenterology"},{"key":"B33","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2011.07.044","article-title":"An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis","volume":"141","author":"Assa'ad","year":"2011","journal-title":"Gastroenterology"},{"key":"B34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/gut.2009.178558","article-title":"Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial","volume":"59","author":"Straumann","year":"2010","journal-title":"Gut"},{"key":"B35","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/MPG.0000000000001840","article-title":"Safety and efficacy of reslizumab for children and adolescents with eosinophilic esophagitis treated for 9 years","volume":"66","author":"Markowitz","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B36","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/j.gastro.2018.10.051","article-title":"RPC4046, a monoclonal antibody against IL13, reduces histologic and endoscopic activity in patients with eosinophilic esophagitis","volume":"156","author":"Hirano","year":"2019","journal-title":"Gastroenterology"},{"key":"B37","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaci.2014.07.049","article-title":"Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis","volume":"135","author":"Rothenberg","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2019.09.042","article-title":"Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis","volume":"158","author":"Hirano","year":"2020","journal-title":"Gastroenterology"},{"key":"B39","doi-asserted-by":"crossref","article-title":"Dupilumab improves health-related quality of life and reduces symptom burden in patients with eosinophilic esophagitis: results from part a of a randomized, placebo-controlled, three-part, phase 3 study","author":"Dellon","DOI":"10.1016\/j.jaci.2020.12.347"},{"key":"B40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaci.2019.10.027","article-title":"Emerging therapies for eosinophilic esophagitis","volume":"145","author":"Greuter","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/all.12096","article-title":"Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis","volume":"68","author":"Straumann","year":"2013","journal-title":"Allergy"},{"key":"B42","doi-asserted-by":"crossref","first-page":"e00099","DOI":"10.14309\/ctg.0000000000000099","article-title":"A novel allergen-specific immune signature-directed approach to dietary elimination in eosinophilic esophagitis","volume":"10","author":"Dellon","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"B43","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1056\/NEJMoa2012047","article-title":"Anti-Siglec-8 antibody for eosinophilic gastritis and duodenitis","volume":"383","author":"Dellon","year":"2020","journal-title":"N Engl J Med"},{"key":"B44","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1016\/j.jaip.2021.07.031","article-title":"Emerging therapies for eosinophilic gastrointestinal diseases","volume":"9","author":"Peterson","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B45","doi-asserted-by":"crossref","first-page":"e126219","DOI":"10.1172\/jci.insight.126219","article-title":"Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis","volume":"4","author":"Youngblood","year":"2019","journal-title":"JCI Insight"},{"key":"B46","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1053\/j.gastro.2021.02.016","article-title":"In esophageal squamous cells from eosinophilic esophagitis patients, Th2 cytokines increase eotaxin-3 secretion through effects on intracellular calcium and a non-gastric proton pump","volume":"160","author":"Odiase","year":"2021","journal-title":"Gastroenterology"},{"key":"B47","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.cgh.2018.03.024","article-title":"Vedolizumab Treatment May Reduce Steroid Burden and Improve Histology in Patients With Eosinophilic Gastroenteritis","volume":"16","author":"Kim","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B48","doi-asserted-by":"crossref","first-page":"e232558","DOI":"10.1136\/bcr-2019-232558","article-title":"Treatment-resistant eosinophilic oesophagitis successfully managed with tofacitinib","volume":"12","author":"Mendoza Alvarez","year":"2019","journal-title":"BMJ Case Rep"}],"container-title":["Allergy and Asthma Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ocean\/aap\/2022\/00000043\/00000003\/art00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T04:33:50Z","timestamp":1651898030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.2500\/aap.2022.43.220014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,1]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5,1]]}},"alternative-id":["1088-5412(20220501)43:3L.178;1-"],"URL":"https:\/\/doi.org\/10.2500\/aap.2022.43.220014","relation":{},"ISSN":["1088-5412"],"issn-type":[{"value":"1088-5412","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,1]]}}}